AR090959A1 - Analogos de hexadepsipeptidos como compuestos anticancerigenos - Google Patents
Analogos de hexadepsipeptidos como compuestos anticancerigenosInfo
- Publication number
- AR090959A1 AR090959A1 ARP130101551A ARP130101551A AR090959A1 AR 090959 A1 AR090959 A1 AR 090959A1 AR P130101551 A ARP130101551 A AR P130101551A AR P130101551 A ARP130101551 A AR P130101551A AR 090959 A1 AR090959 A1 AR 090959A1
- Authority
- AR
- Argentina
- Prior art keywords
- compound
- formula
- compounds
- bangeous
- hexadepsipeptides
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 12
- 239000000203 mixture Substances 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 238000000855 fermentation Methods 0.000 abstract 1
- 230000004151 fermentation Effects 0.000 abstract 1
- 230000002538 fungal effect Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/15—Depsipeptides; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K11/00—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K11/02—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof cyclic, e.g. valinomycins ; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
La presente se refiere a un compuesto aislado de la fórmula (1) o derivados o sales farmacéuticamente aceptables de la misma. Incluye todas las formas isoméricas o tautoméricas del compuesto de fórmula (1) o sus derivados. La presente se refiere asimismo a procesos para la producción del compuesto de la fórmula (1) mediante la fermentación de la cepa fúngica de Actinomycetos (PM0895172/MTCC 5684), composiciones farmacéuticas que comprenden el compuesto de fórmula (1) como ingrediente activo; y el uso de dichos compuestos o composiciones que los contengan en el tratamiento del cáncer. Reivindicación 1: Un compuesto de la fórmula (1); en la que el compuesto de la fórmula (1), cuando el enlace ⁻ ⁻ ⁻ ⁻ ⁻ representa un enlace simple y R¹ es H; se hace referencia a dicho compuesto como el compuesto de la fórmula (1a); y cuando el enlace ⁻ ⁻ ⁻ ⁻ ⁻ es un doble enlace y R¹ está ausente; se hace referencia a dicho compuesto como el compuesto de la fórmula (1b); o un isómero o tautómero o una mezcla de ambos, o un derivado o su sal farmacéuticamente aceptable.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261643814P | 2012-05-07 | 2012-05-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR090959A1 true AR090959A1 (es) | 2014-12-17 |
Family
ID=49550252
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP130101551A AR090959A1 (es) | 2012-05-07 | 2013-05-07 | Analogos de hexadepsipeptidos como compuestos anticancerigenos |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US9475842B2 (es) |
| EP (1) | EP2847212A4 (es) |
| JP (1) | JP2015517485A (es) |
| KR (1) | KR20150008173A (es) |
| CN (1) | CN104603147A (es) |
| AR (1) | AR090959A1 (es) |
| AU (1) | AU2013257609A1 (es) |
| BR (1) | BR112014027843A2 (es) |
| CA (1) | CA2872813A1 (es) |
| IL (1) | IL235600A0 (es) |
| IN (1) | IN2014MN02433A (es) |
| MX (1) | MX2014013498A (es) |
| NZ (1) | NZ702684A (es) |
| RU (1) | RU2014149097A (es) |
| WO (1) | WO2013168075A1 (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102389725B1 (ko) * | 2020-02-14 | 2022-04-25 | 서울대학교산학협력단 | 피페라진산을 함유하는 사이클릭 펩티드 화합물, 이의 생산 방법, 및 이의 용도 |
| WO2022178403A1 (en) * | 2021-02-22 | 2022-08-25 | Lodo Therapeutics Corporation | Hexadepsipeptide compounds and methods of using the same |
| WO2023081764A1 (en) * | 2021-11-05 | 2023-05-11 | Zymergen Inc. | Hexadepsipeptide compounds and methods of using the same |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3148851B2 (ja) * | 1994-10-25 | 2001-03-26 | 積水化学工業株式会社 | 新規抗腫瘍剤 |
| US5858971A (en) * | 1994-10-25 | 1999-01-12 | Sekisui Chemical Co., Ltd. | Cyclic peptide and method of making same by culturing a strain of actinomyces S. nobilis |
| JPH11269090A (ja) * | 1998-03-24 | 1999-10-05 | Sekisui Chem Co Ltd | 医療材料 |
| WO2007126849A1 (en) * | 2006-03-29 | 2007-11-08 | Thallion Pharmaceuticals Inc. | Cyclic hexadepsipeptides, processes for their production and their use as pharmaceuticals |
-
2013
- 2013-05-06 IN IN2433MUN2014 patent/IN2014MN02433A/en unknown
- 2013-05-06 MX MX2014013498A patent/MX2014013498A/es unknown
- 2013-05-06 BR BR112014027843A patent/BR112014027843A2/pt not_active IP Right Cessation
- 2013-05-06 CA CA2872813A patent/CA2872813A1/en not_active Abandoned
- 2013-05-06 US US14/399,321 patent/US9475842B2/en not_active Expired - Fee Related
- 2013-05-06 WO PCT/IB2013/053613 patent/WO2013168075A1/en active Application Filing
- 2013-05-06 CN CN201380036225.6A patent/CN104603147A/zh active Pending
- 2013-05-06 RU RU2014149097A patent/RU2014149097A/ru not_active Application Discontinuation
- 2013-05-06 EP EP13787676.9A patent/EP2847212A4/en not_active Withdrawn
- 2013-05-06 NZ NZ702684A patent/NZ702684A/en not_active IP Right Cessation
- 2013-05-06 AU AU2013257609A patent/AU2013257609A1/en not_active Abandoned
- 2013-05-06 JP JP2015510921A patent/JP2015517485A/ja active Pending
- 2013-05-06 KR KR1020147034422A patent/KR20150008173A/ko not_active Application Discontinuation
- 2013-05-07 AR ARP130101551A patent/AR090959A1/es unknown
-
2014
- 2014-11-09 IL IL235600A patent/IL235600A0/en unknown
-
2016
- 2016-08-18 US US15/240,509 patent/US20160354430A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| NZ702684A (en) | 2016-08-26 |
| BR112014027843A2 (pt) | 2017-06-27 |
| CN104603147A (zh) | 2015-05-06 |
| WO2013168075A1 (en) | 2013-11-14 |
| IN2014MN02433A (es) | 2015-08-21 |
| IL235600A0 (en) | 2015-01-29 |
| US20160354430A1 (en) | 2016-12-08 |
| CA2872813A1 (en) | 2013-11-14 |
| RU2014149097A (ru) | 2016-06-27 |
| KR20150008173A (ko) | 2015-01-21 |
| EP2847212A1 (en) | 2015-03-18 |
| EP2847212A4 (en) | 2015-12-30 |
| US20150080312A1 (en) | 2015-03-19 |
| JP2015517485A (ja) | 2015-06-22 |
| MX2014013498A (es) | 2015-11-13 |
| US9475842B2 (en) | 2016-10-25 |
| AU2013257609A1 (en) | 2014-12-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2018003681A1 (es) | Derivados de ácido borónico y usos terapéuticos de los mismos | |
| CO2017013708A2 (es) | Macrociclos peptídicos contra acinetobacter baumannii. | |
| CU20150014A7 (es) | Análogos de piridazina 1,4-disustituida y métodos para el tratamiento de condiciones relacionadas con la deficiencia de smn | |
| CR20160191A (es) | Compuestos derivados de piridilo bicíclicos fusionados a anillo como inhibidores de fgfr4 | |
| UY35586A (es) | Derivados de la pirazolopirrolidina y su uso en el tratamiento de enfermedades | |
| CU20160192A7 (es) | Derivados de indano e indolina útiles como activadores de la guanilato ciclasa soluble | |
| CO2018004857A2 (es) | Derivados de dihidroimidazopirazinona usados en el tratamiento del cáncer | |
| UY35353A (es) | Un inhibidor de mdm2 derivado de ácido benzoico para el tratamiento del cáncer | |
| CR20150419A (es) | Derivados sustituidos del ácido bisfenil butanóico fosfónico como inhibidores de la nep | |
| PE20181778A1 (es) | Derivados de indolina sustituidos como inhibidores de la replicacion viral del dengue | |
| SV2011004077A (es) | Derivados aminobutiricos sustituidos como inhibidores de neprilisina | |
| UY32490A (es) | Inhibidores de beta-secretasa | |
| UY33731A (es) | ?derivados de ácido amino-fenil-pentanoico sustituidos como inhibidores de nep? | |
| CR20120047A (es) | Formulacion farmaceutica | |
| BR112020008664A8 (pt) | Composto macrocíclico que atua como inibidor de weel e aplicações do mesmo | |
| BR112017016817A2 (pt) | derivados heterocíclicos formilados como inibidores de fgfr4 | |
| UY36123A (es) | Derivados de carboxamida | |
| UY36124A (es) | Derivados de carboxamida | |
| AR105821A1 (es) | COMPUESTOS ÚTILES PARA INHIBIR ROR-g-T | |
| CO2019001644A2 (es) | Derivado de triazolopirazinona útil como un inhibidor de pde1 humana | |
| AR090959A1 (es) | Analogos de hexadepsipeptidos como compuestos anticancerigenos | |
| CL2020001277A1 (es) | Derivados de piridinona y su uso como inhibidores selectivos de alk-2. | |
| UY35323A (es) | Derivados sustituidos del ácido bisfenil butanóico como inhibidores de la nep con una mejorada efic acia in vivo | |
| AR092627A1 (es) | Derivados glucopiranosidos de urea | |
| PH12020550124A1 (en) | Pharmaceutical composition for enhancing antitumor effect by immune checkpoint inhibitor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |